News
Given the scope of the risk, attention has turned to metabolic hormones that regulate appetite, satiety, and glucose metabolism, particularly glucagon-like peptide-1 (GLP-1). Its appetite ...
Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.
1don MSN
Mounjaro is generally considered safe for use under medical supervision, especially for individuals who are overweight or ...
When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...
4d
GlobalData on MSNSCHOTT Pharma invests in RTU cartridge capacity expansionSCHOTT Pharma has announced an investment of €100m ($114m) to expand its manufacturing capacity for sterile RTU cartridges.
Mounjaro is the brand name for tirzepatide, a prescription medication developed by Eli Lilly that is primarily used to treat ...
TUCSON, AZ / ACCESS Newswire / June 2, 2025 / Umbrella Labs, a leading supplier of advanced research chemicals, announced the expansion of its peptide catalog to include Retatrutide (LY3437943), an ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...
6d
Onlymyhealth on MSNFirst Ozempic Face, Now Ozempic Teeth: What To Know About The Latest Side Effect Of Weight Loss DrugOzempic teeth is the latest concern associated with the ‘miracle’ weight loss drug Ozempic Read to know more about this side ...
Bariatric surgeries: These are operations that remove or bypass part of the stomach for the purpose of losing weight and ...
1d
NDTV Profit on MSNObesity Drugs Pick Pace In India — Can Consumption Sector Withstand A $21 Billion Disruption? | Open InterestIn this edition of Open Interest, we look at how the focus on GLP-1 could reduce household dietary intake and grocery bills.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results